Equities

Gushengtang Holdings Ltd

Gushengtang Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)33.85
  • Today's Change-1.50 / -4.24%
  • Shares traded957.60k
  • 1 Year change-31.20%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gushengtang Holdings Ltd is a China-based company mainly engaged in traditional Chinese medicine (TCM) medical and health services. The Company operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The Company's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The Company also provides honey, Ejiao cake and other nutritional products.

  • Revenue in HKD (TTM)2.90bn
  • Net income in HKD286.08m
  • Incorporated2014
  • Employees2.90k
  • Location
    Gushengtang Holdings LtdNo. 761 Dongfeng East RoadUnit 01-04, 36 Floor, Lifeng CentreGUANGZHOU ChinaCHN
  • Websitehttps://www2.gstzy.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mega Genomics Ltd171.56m34.26m1.78bn214.0046.802.5435.4910.360.16370.16370.81423.010.203830.130.985749,177.404.07--4.67--57.99--19.97--5.42--0.0588--3.82--270.50------
Rici Healthcare Holdings Ltd3.16bn349.57m1.91bn9.65k5.461.472.560.60440.21980.21981.990.8190.667946.2311.07335,456.308.253.2414.165.7839.5237.0012.345.930.61144.720.6610.0026.0116.8556.06--2.51--
Chaoju Eye Care Holdings Ltd1.52bn230.69m2.05bn2.65k8.660.8025.551.350.3350.3352.203.620.497913.4821.16583,673.107.328.088.369.5644.9443.8114.7015.474.9526.360.071551.5738.3316.7021.9242.68-2.33--
C-Mer Medical Holdings Ltd1.90bn63.00m2.57bn2.19k40.531.388.221.360.05060.05061.521.490.69232.3037.42579,346.803.540.92374.371.1232.0629.955.111.441.8212.640.16745.3311.0934.98383.427.8128.01--
Yunkang Group Ltd853.53m-297.66m4.35bn1.46k--2.11--5.10-0.4945-0.49451.423.320.183830.130.482565,252.10-6.386.70-11.8211.1934.2742.42-34.7310.991.73-2.460.379519.89-76.278.38-127.10--33.22--
Adicon Holdings Ltd3.35bn241.33m4.65bn5.46k19.322.4210.331.390.33180.33184.612.650.662613.031.80586,531.905.22--8.80--40.93--7.87--1.916.110.4213---32.15---65.50------
China Resources Medical Holdings Com Ltd10.71bn315.76m5.03bn19.64k15.540.75914.790.46980.24980.24988.475.110.618825.756.16530,909.402.193.244.394.8018.5920.293.546.600.7904195.560.224627.9527.9237.46-3.07-9.7753.23-10.66
Gushengtang Holdings Ltd2.90bn286.08m8.55bn2.90k31.083.4520.022.941.141.1411.5610.240.825113.3516.831,091,647.008.15-4.879.96-9.9130.2837.099.88-6.672.43--0.1351--43.0126.1839.45--26.99--
Jinxin Fertility Group Ltd3.11bn333.90m8.62bn3.78k25.530.792313.052.770.1230.1231.153.960.192731.6722.00951,368.702.082.642.413.0141.1941.7610.8114.900.53199.420.197541.5217.9524.78184.6015.6552.59--
Genertec Universal Medical Group Co Ltd14.56bn2.22bn9.04bn21.52k4.320.44023.020.62081.111.117.1210.860.161222.130.458690,619.302.682.964.234.7133.7239.2316.6519.151.34--0.693330.5813.0626.017.028.37119.406.06
Concord Healthcare Group Co Ltd507.51m-387.45m10.77bn691.00--5.26--21.23-0.5409-0.54090.70852.860.084113.026.12692,377.20-7.38---9.97---13.68---87.66--0.4955-3.000.5713--14.08--31.09------
Hygeia Healthcare Holdings Co Ltd5.05bn787.77m11.15bn8.37k14.291.5810.472.211.251.257.9911.270.470718.085.89612,735.607.376.758.868.3431.3232.1515.6515.210.967620.200.29179.3227.5739.7043.24204.9926.48--
Ping An Healthcare and Technology Co Ltd4.88bn-22.91m16.16bn1.45k--1.12152.193.31-0.0214-0.02144.5112.850.276621.343.842,784,958.00-0.1787-5.23-0.2172-6.4432.2826.28-0.646-13.964.71--0.0044---24.686.9649.28---26.31--
Data as of Nov 22 2024. Currency figures normalised to Gushengtang Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

14.91%Per cent of shares held by top holders
HolderShares% Held
China Asset Management Co., Ltd.as of 30 Jun 20248.15m3.35%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20246.64m2.72%
The Vanguard Group, Inc.as of 06 Nov 20245.82m2.39%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20242.51m1.03%
Foresight Fund Management Co., Ltd.as of 30 Jun 20242.50m1.03%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20242.21m0.91%
Huashang Fund Management Co., Ltd.as of 30 Jun 20242.20m0.90%
China Southern Asset Management Co., Ltd.as of 30 Jun 20242.16m0.89%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 20242.13m0.87%
BlackRock Fund Advisorsas of 07 Nov 20242.02m0.83%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.